The Promise of Immuno-Oncology

AACR Virtual Patient Advocate Forum

The Promise of Immuno-Oncology

May 4, 2021

Virtual

The rapid development of immuno-oncology therapies for cancer is transforming the cancer treatment landscape and bolstering hope for many cancer patients. But why doesn’t it create a durable response for all patients with cancer? This virtual AACR Patient Advocate Forum explored the field of immuno-oncology, highlighted how immuno-oncology harnesses the body’s immune system to prevent and fight cancer, and discussed why some cancers are resistant to this approach.

MODERATOR

Anna D. Barker, Ellison Institute for Transformative Medicine of USC, Los Angeles, California

SPEAKERS

Elizabeth M. Jaffee, Sidney Kimmel Cancer Center, Johns Hopkins, Baltimore, MD

Melinda Bachini, AACR Scientist↔Survivor Program®, Cholangiocarcinoma Foundation, Billings, MT

David L. Rimm, Yale School of Medicine, New Haven, CT

Suzanne L. Topalian, Sidney Kimmel Cancer Center, Johns Hopkins, Baltimore, MD

Carl H. June, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Program Agenda Speaker Bios

AACR Patient Advocate Forums

The AACR is committed to providing educational programming to patients with cancer and patient advocacy communities to support their collective mission to find cures for all cancers. AACR Patient Advocate Forums invite leaders from patient advocacy, academia, industry, and health care communities to discuss pressing topics and the latest discoveries in cancer research. These virtual forums are provided quarterly at no cost to attendees and open to the public.

The Promise of Immuno-Oncology

AACR Virtual Patient Advocate Forum